Pharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection-Reference-Cited by-同舟云学术

Pharmacokinetics of nucleoside/nucleotide reverse transcriptase inhibitors for the treatment and prevention of HIV infection

Published:2020-06-07 Issue:7 Volume:16 Page:551-564
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Wonganan Piyanuch¹^ORCID,Limpanasithikul Wacharee¹,Jianmongkol Suree²,Kerr Stephen J.³⁴,Ruxrungtham Kiat⁴⁵

Affiliation:

1. Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

2. Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand

3. Biostatistics Excellence Centre, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

4. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

5. Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1772755

Reference116 articles.

1. U.S. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV.[cited 2020 Apr 27]. Available from: https://aidsinfonihgov/guidelines/html/1/adult-and-adolescent-arv/11/what-to-start

2. Survival in HIV-Infected Patients Who Have Received Zidovudine: Comparison of Combination Therapy with Sequential Monotherapy and Continued Zidovudine Monotherapy

3. Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients

4. U.S. Food & Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. [cited 2020 Apr 27]. Available from: https://wwwfdagov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic

5. World Heath Organization. Update of recommendations on first- and second-line antiretroviral regimens. [cited 2020 Apr 12]. Available from: https://appswhoint/iris/bitstream/handle/10665/325892/WHO-CDS-HIV-1915-engpdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse transcriptase;Metalloenzymes;2024

2. Pharmacokinetic Drug-Drug Interactions Involving Antiretroviral Agents: An Update;Current Drug Metabolism;2023-07

3. Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration;Journal of Antimicrobial Chemotherapy;2023-04-12

4. The future of long-acting agents for preexposure prophylaxis;Current Opinion in HIV and AIDS;2022-07

5. Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function;Expert Review of Clinical Pharmacology;2022-05-04